Powerful Medical
1. June 2021

Powerful Medical opening branch in Israel

Over the past months, we have significantly strengthened our collaboration on numerous projects with our Israeli partners, such as Rabin Medical Center and Tel Aviv Medical Center, culminating in the incorporation of our Israeli subsidiary with an office on the 16th floor of the latter. We’re right in the center of all medical action and innovation, with access to local medical data to further improve the performance of our AI algorithms!

Israel is considered to be the “factory of unicorns” or “the Silicon Valley of the Middle East”, with startups such as WeWork, Waze, eToro and Fiverr originating from here.

Most tech giants have AI R&D labs in the region, giving us access to top talent, funding and technical resources.

Pictured are (from left to right): Roy Ramon (Chairman of the Board), Martin Herman (CEO) and Dr. Leor Perl (Chairman of the Scientific Board).

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Wellens syndrom ECG - Blog

Wellens’ Syndrome: Are You Prepared to Prevent Acute Coronary Occlusions?

Wellens' Syndrome is a condition representing a reperfusion state post coronary artery occlusion, marked by distinctive ECG changes. This condition demands urgent recognition and intervention to prevent the progression to an extensive anterior wall myocardial infarction (MI).

Gearing Up for the US Market: PMcardio Showcases at ACC.24

We're thrilled to share our experience at the American College of Cardiology's 24th annual meeting (ACC.24) in Atlanta, where we showcased our AI-powered ECG interpretation platform

Join 25,000 healthcare professionals who are already taking advantage of AI